Earnings Call Transcripts
Access detailed transcripts and key takeaways from company earnings calls
All Earnings Calls
Danaher Corporation Fourth Quarter 2025 Earnings Call - Bioprocessing Strength Anchors 2026 Guide (3%-6% Core Revenue, $8.35-$8.50 EPS)
Danaher closed 2025 with clear momentum in bioprocessing and enough diagnostic tailwinds to beat street expectations, but management is deliberately conservative on equipment recovery and life science...
- Full year 2025 sales $24.6 billion; core revenue increased 2% year over year.
- Adjusted operating profit margin for 2025 was 28.2%; adjusted diluted EPS $7.80, up 4.5% versus prior year.
- Free cash flow for 2025 was $5.3 billion, with free cash flow to net income conversion of approximately 145%, the 34th consecutive year above 100%.
- +12 more takeaways
Starbucks Q1 Fiscal 2026 Earnings Call - Turnaround Gains Traction as Transactions Drive Top-Line Growth
Starbucks says the long-awaited turnaround is showing up where it matters, in transactions. Q1 top line beat the headline skeptics: revenue rose 5% to $9.9 billion, global comps accelerated to +4%, an...
- Q1 revenue $9.9 billion, up 5% year over year, with global comparable store sales +4%.
- U.S. company-operated comps +4%, driven by transactions up 3%, the first positive transaction growth in eight quarters.
- Starbucks Rewards 90-day active members reached a record 35.5 million, and Rewards transactions grew year over year for the first time in eight quarters.
- +12 more takeaways
Monro Inc Q3 FY2026 Earnings Call - Operational overhaul starts to pay off with positive comps, margin lift, and real estate monetization
Monro says its fiscal Q3 was the quarter the turnaround began to feel real. After closing 145 underperforming locations and beefing up marketing, merchandising, and field tools, the chain delivered po...
- Sales declined 4.0% to $293.4 million in Q3, primarily due to the closure of 145 underperforming stores earlier in the fiscal year.
- Comparable store sales for continuing locations increased 1.2% in Q3, marking the fourth consecutive quarter of positive comps and the first positive two-year stack in over two years when adjusting for holiday timing.
- Tire category strength: tire sales were up 5% year-over-year, while tire units were down 1%, suggesting mix and pricing gains.
- +16 more takeaways
Teva Pharmaceutical Industries Q4 2025 Earnings Call - Innovation-led growth is real, but milestone cash and inventory quirks muddy the picture
Teva closed 2025 on a clear theme, one they have been selling since the Pivot to Growth launch: the company is no longer a pure generics shop, it is a biopharma company driven by a fast-growing innova...
- Management doubled down on the Pivot to Growth narrative: Teva says its business is shifting from generics to a diversified biopharma with four strategic pillars and focused capital allocation.
- Q4 GAAP revenue was reported at approximately $4.2 billion, up 2% year-over-year in USD (down 1% in local currency). Q4 GAAP net income was $480 million, GAAP EPS $0.41.
- Company-reported adjusted EBITDA rose 12% to $5.3 billion (management figure), and non-GAAP gross margin for the full year was 54.7%, above guidance range; non-GAAP operating margin slipped to 26.7% due to higher OpEx investments.
- +13 more takeaways
Extreme Networks Q2 Fiscal Year 2026 Earnings Call - Platform One AI sales lift revenue and share gains, installations dent near-term margins
Extreme reported a clean beat: revenue of $318 million, up 14% year over year, driven by accelerating SaaS and product momentum. Management leaned hard into Platform One, calling it agentic AI and say...
- Revenue beat and growth: Q2 revenue $318 million, up 14% year over year and above the high end of guidance, marking the seventh consecutive quarter of revenue growth.
- SaaS ARR acceleration: SaaS ARR reached $227 million, up 25% year over year, driven largely by Platform One momentum.
- Record subscription bookings: Management said subscription bookings were the strongest on record, with Platform One bookings roughly twice internal targets for the quarter.
- +16 more takeaways
New Oriental FY2026 Q2 Earnings Call - K-12 Rebound and Cost Discipline Lift Revenue 14.7% and Non‑GAAP Op Margin +470 bps
New Oriental posted a crisp quarter: total net revenue rose 14.7% year‑over‑year to $1.19 billion, while non‑GAAP operating income more than tripled to $89.1 million and non‑GAAP net income jumped 68....
- Total net revenue $1.19 billion in Q2, up 14.7% year‑over‑year.
- Non‑GAAP operating income $89.1 million, up 206.9% year‑over‑year; non‑GAAP net income $72.9 million, up 68.6%.
- Non‑GAAP operating margin expanded materially, management cited roughly +470 basis points year‑over‑year (over 4 percentage points).
- +13 more takeaways
GE Vernova Q4 2025 Earnings Call - Gas power surge drives $150B backlog and lifts 2026 outlook
GE Vernova closed 2025 with a dramatic tilt toward gas and electrification, booking $59 billion of orders, expanding total backlog to $150 billion, and adding roughly $8 billion of incremental equipme...
- Backlog climbed to $150 billion at year-end 2025, up about $31 billion or more than 25% year-over-year, split roughly $64 billion equipment and $86 billion services.
- 2025 orders totaled $59 billion, with Q4 orders of $22.2 billion and a book-to-bill of approximately 2x; equipment orders grew 91% in Q4 and services orders grew 22%.
- Gas power momentum is the headline: gas equipment backlog and slot reservations rose from 62 GW to 83 GW sequentially in Q4, and management expects roughly 100 GW under contract by year-end 2026.
- +13 more takeaways
UMC Q4 2025 Earnings Call - 22nm Mix Shift and Packaging, Photonics Push Set Stage for 2026-27 Upside
UMC reported a steady Q4 2025, with revenue of TWD 61.8 billion, gross margin of 30.7%, and EPS of NT$0.81, while utilization held near 78%. Management anchored 2026 guidance to flat wafer shipments i...
- Q4 2025 results were solid and in line with guidance, revenue TWD 61.81 billion, gross margin 30.7%, net income attributable to parent TWD 10.06 billion, EPS NT$0.81.
- Utilization stayed around 78% in Q4, management expects mid-70s utilization in Q1 2026 with wafer shipments flat quarter-on-quarter.
- UMC delivered modest full-year 2025 growth, revenue TWD 237.5 billion (up 2.3% YoY), net income for 2025 about TWD 41.7 billion, EPS 3.34, down from 3.80 in 2024.
- +12 more takeaways
ASML Q4 2025 and Full Year 2025 Earnings Call - AI-driven EUV surge fuels record revenue, orders and backlog
ASML closed 2025 with a bang, reporting a record Q4 and full-year performance driven by a sharp pickup in AI-related demand and a ramp in EUV adoption. Q4 revenue hit EUR 9.7 billion, full-year revenu...
- Q4 2025 net revenue was EUR 9.7 billion, full-year 2025 revenue EUR 32.7 billion, up 16% versus 2024.
- Gross margin was 52.2% in Q4 and 52.8% for the full year, with management guiding 51% to 53% for 2026.
- Net income totaled EUR 2.8 billion in Q4 and EUR 9.6 billion for 2025.
- +12 more takeaways
Elevra Lithium December 2025 Earnings Call - Record revenue and operating cash flow at NAL, but FY26 production guidance trimmed due to lower head grades and high iron
Elevra delivered a paradoxical quarter. North American Lithium posted record quarterly revenue of $66 million, a $12 million operating profit and $13 million operating cash flow, driven by disciplined...
- Record quarter revenue of $66 million at NAL, driven by a 27% increase in average realized FOB price to $998 per ton.
- NAL generated $12 million operating profit and $13 million operating cash flow for the December quarter, demonstrating leverage to higher spodumene prices.
- Spodumene concentrate production fell 15% quarter on quarter to 44,154 dry metric tons, driven by lower feed grade and elevated iron content affecting recoveries.
- +12 more takeaways